Screener
Capricor Therapeutics CAPR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| TOTAL ASSETS | $326,283,517 | $ | $355,949,294 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| CURRENT LIABILITIES | |||
| Accounts payable | $3,927,941 | $ | $1,654,754 |
| Accrued expenses | 10,528,351 | 15,557,646 | |
| Lease liabilities, current | 841,135 | 202,376 | |
| CIRM liability, current | 6,339,862 | 6,421,984 | |
| Deferred revenue, current | 12,000,000 | 12,000,000 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's accounts payable?
- Capricor Therapeutics (CAPR) reported accounts payable of $3.93M in Q1 2026.
- How has Capricor Therapeutics's accounts payable changed year-over-year?
- Capricor Therapeutics's accounts payable decreased by 25.2% year-over-year, from $5.25M to $3.93M.
- What is the long-term trend for Capricor Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), Capricor Therapeutics's accounts payable has grown at a -9.4% compound annual growth rate (CAGR), from $2.72M to $1.65M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Capricor Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude